Physicians' Academy for Cardiovascular Education

Are new Incretin-based treatments changing the fundamentals of diabetes management?

Nov. 6, 2016 - Seoul, Korea - Prof. Sanjay Rajagopalan, MD Cleveland, OH, USA - CDMC 2016 Seoul

This lecture was part of a Cardio Diabetes Master Class 'Contemporary issues in T2DM & cardiovascular risk: Review of latest insights for optimizing patient management' held on November 5-6 2016 in Seoul Korea

Educational information

The educational objectives of this Cardio Diabetes Master Class were:

CME accreditation

The Cardio Diabetes Master Class was accredited by the European Board for Accreditation in Cardiology (EBAC) for 9 CME credit hours

Disclosures

Prof Sanjay Rajagopalan, MD, FACC, FAHA is Chief, Cardiovascular Medicine, Herman Hellerstein Chair of Cardiovascular Research Director, Cardiovascular Research Institute - Professor of Medicine, Case Western Reserve School of Medicine, Cleveland, OH, USA

Funding

The master class is supported by an unrestricted educational grant provided by Takeda Pharmaceuticals